Remdesivir for Adults With COVID-19

Annals of Internal Medicine - Tập 174 Số 2 - Trang 209-220 - 2021
Timothy J Wilt1, Anjum S. Kaka2, Roderick MacDonald3, Nancy Greer3, Adam J. Obley4, Wei Duan‐Porter5
1Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, and University of Minnesota School of Medicine, Minneapolis, Minnesota (T.J.W.)
2Minneapolis VA Section of Infectious Diseases and University of Minnesota School of Medicine, Minneapolis, Minnesota (A.S.K.)
3Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research, Minneapolis, Minnesota (R.M., N.G.)
4VA Portland Health Care System and Oregon Health & Science University School of Medicine, Portland, Oregon (A.O.)
5Minneapolis VA Evidence Synthesis Program, Center for Care Delivery and Outcomes Research and University of Minnesota School of Medicine, Minneapolis, Minnesota (W.D.)

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1001/jama.2020.6775

10.1056/NEJMp2009457

10.1056/NEJMoa1910993

10.1038/s41467-019-13940-6

10.1056/NEJMoa2007764

10.1056/NEJMoa2015301

10.1016/j.jclinepi.2017.08.008

10.1016/S0140-6736(20)31022-9

10.1001/jama.2020.16349

10.1002/jmv.26443

10.1111/eci.13383

10.1016/j.virusres.2020.198137

10.1136/bmj.m2980

10.7326/M20-4044

Thông tin
Thông tin xuất bản

Annals of Internal Medicine

Tập 174 Số 2

209-220

Thông tin tác giả